264
Participants
Start Date
February 17, 2021
Primary Completion Date
June 1, 2022
Study Completion Date
June 1, 2022
nirmatrelvir/ritonavir
Tablets 300/100mg, 2 times a day with 12 ±2 hours interval for 5 days
Standard of care
The administration of 'Standard of care' drugs was done according to the regimen recommended in the 'COVID-19 TreatmentGuidelines' validated at the time of the study
"Regional Budgetary Healthcare Institution Ivanovo Clinical Hospital", Ivanovo
Kirov State Medical University of Ministry of Health of the Russian Federation, Kirov
State Budgetary Healthcare Institution City Clinical Hospital named after S. I. Spasokukotskiy of Moscow Healthcare Department, Moscow
Regional Clinic Hospital of Ryazan, Ryazan
Ryazan State Medical University named after academician I.P. Pavlov of Ministry of Health of the Russian Federation, Ryazan
Avrora MedFort, LLC, Saint Petersburg
OrCli Hospital, LLC, Saint Petersburg
Ogarev Mordova State University of Ministry of Health of the Russian Federation, Saransk
"Regional State Budgetary Healthcare Institution Clinical Hospital No. 1", Smolensk
Smolensk State Medical University of Ministry of Health of the Russian Federation, Smolensk
"State Budgetary Healthcare Institution of the Yaroslavl Oblast Clinical Hospital No.3", Yaroslavl
Sponsor GmbH
OTHER
Promomed, LLC
OTHER